Torrent Pharmaceuticals Q4 Results
- BSE: 500420
- NSE: TORNTPHARM
- ISIN: INE685A01028
- Sector: Biotechnology & Drugs
BSE
4,888.90
-26.60 (-0.54%)
-26.60 (-0.54%)Volume71.84 K
Updated: Tue 11 Aug, 2026 | 15:14:55
NSE
4,886-38.00 (-0.77%)
-38.00 (-0.77%)Volume3.61 L
Updated: Tue 11 Aug, 2026 | 15:14:57
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Torrent Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 3,414.89 | 2,431.00 | 40.47% | 2,065.46 | 53.81% |
| Depreciation/ Amortization | 507.87 | 206.00 | 146.54% | 203.27 | 152.76% |
| Operating Income | 781.84 | 872.00 | -10.34% | 679.38 | 5.82% |
| Net Income | 389.37 | 635.00 | -38.68% | 449.38 | -21.85% |
| Other Operating Expenses Total | 1,038.25 | 765.00 | 35.72% | 696.58 | 47.72% |
| Net Income Before Taxes | 529.19 | 814.00 | -34.99% | 631.11 | -20.40% |
| Total Revenue | 4,196.73 | 3,303.00 | 27.06% | 2,744.84 | 41.83% |
| Selling/ General/ Admin Expenses Total | 787.85 | 651.00 | 21.02% | 486.40 | 40.34% |
| Diluted Normalized EPS | 12.85 | 19.00 | -32.39% | 13.26 | -15.74% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.